Barts Life Sciences (BLS) is at the core of establishing East London as a major new Life Sciences Cluster, with a key focus on population health, disease prediction and precision medicine.
A powerful partnership between Barts Health (the largest NHS Trust in the UK) and Queen Mary University of London (one of the best research-intensive universities in the country), BLS offers integrated access to the capabilities of both organisations, accelerating the translation of impactful research and innovation to clinical deployment.
Working with a large, diverse population of over 2.5 million people and a growing range of industry collaborators, BLS offers a “bench to bedside” opportunity with access to a wealth of diverse data through our Precision Medicine Data Platform, capacity for phase 1-3 large-scale clinical trials in a new purpose-built facility, and availability of three national oncology biobanks.
The planned Life Sciences Cluster, at over 1 million ft2 with substantial new lab capacity, will be situated adjacent to the Royal London hospital and Queen Mary University, providing access to clinicians, academics and new graduates. The Cluster will bring together an interconnected range of primarily industrial health-related organisations in close physical proximity, presenting an opportunity to drive inclusive growth, with high-quality employment, that will support over time a greater prospect for enhanced regional, national and global health outcomes.
We would love to discuss more with you: bartshealth.bartslifesciences@nhs.net
